Switching to Lurasidone following 12  months of treatment with Risperidone: results of a 6-month, open-label study

Patients with a diagnosis of schizophrenia are at an increased risk for developing metabolic syndrome, which is associated with greater cardiovascular morbidity and mortality. Treatment with some commonly used...

Source: BMC Psychiatry - May 5, 2020 Category: Psychiatry Authors: Greg W. Mattingly, Peter M. Haddad, Michael Tocco, Jane Xu, Debra Phillips, Andrei Pikalov and Antony Loebel Tags: Research article Source Type: research